ARCHIVES

Also von Eschenbach Role in Industry Program Raises New Concerns of Conflict of Interest.

This article is from The Cancer Letter archive.

Vol. 32 No. 42 | November 22, 2006

Download PDF Visit The Full Archive

Related Articles

Supreme Court Declines Appeal on Access to Experimental Therapies.

January 18, 2008

BMT Ok For some Stage IV Breast Cancer, Blues Advisor Say

March 8, 1996

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

May 25, 2001

Seer Gets Extra $5000,000 to Permit Addition Of One Registry To Braden Coverage Of Blacks, Hispanics

October 22, 1982

NCI R01 Payline Stays At 12th Percentile for FY07.

February 9, 2007

OMB To Seek Rescission In ’79 Appropriation For NIH; NCI Cut Would BE $29 Million; FY 1980 Budget Request Will Be $912.7 Million

December 8, 1978